BNTC
Benitec Biopharma Ltd ADR
NASDAQ: BNTC · HEALTHCARE · BIOTECHNOLOGY
$12.05
-0.82% today
Updated 2026-04-30
Market cap
$423.73M
P/E ratio
—
P/S ratio
2,770.13x
EPS (TTM)
$-1.08
Dividend yield
—
52W range
$10 – $17
Volume
0.2M
Benitec Biopharma Ltd ADR (BNTC) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-33.50%
ROA
-22.40%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2013 | $545734.00 | $-6.42M | 67.73% | -1,494.87% | -1,177.09% |
| 2014 | $1.02M | $-10.84M | 96.30% | -1,414.88% | -1,064.66% |
| 2015 | $829127.00 | $-8.83M | 96.30% | -1,607.59% | -1,064.66% |
| 2016 | $346506.00 | $-18.50M | 70.04% | -7,204.20% | -5,340.09% |
| 2017 | $450311.00 | $-4.37M | 53.58% | -3,536.22% | -970.99% |
| 2018 | $455446.00 | $-8.55M | 27.26% | -1,877.75% | -1,877.42% |
| 2019 | $11.32M | $2.87M | 96.23% | 17.70% | 25.34% |
| 2020 | $97000.00 | $-8.27M | 290.72% | -8,537.11% | -8,529.90% |
| 2021 | $59000.00 | $-13.88M | -108.47% | -23,044.07% | -23,528.81% |
| 2022 | $73000.00 | $-18.21M | 87.67% | -24,457.53% | -24,942.47% |
| 2023 | $75000.00 | $-19.56M | -408.00% | -25,441.33% | -26,082.67% |
| 2024 | $216000.00 | $-21.75M | -158.80% | -10,462.04% | -10,069.91% |
| 2025 | $0.00 | $-37.92M | — | — | — |